請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/74835
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 謝銘鈞 | |
dc.contributor.author | Shin-Yu Lee | en |
dc.contributor.author | 李欣瑜 | zh_TW |
dc.date.accessioned | 2021-06-17T09:08:31Z | - |
dc.date.available | 2024-12-03 | |
dc.date.copyright | 2019-12-03 | |
dc.date.issued | 2019 | |
dc.date.submitted | 2019-11-07 | |
dc.identifier.citation | (1) Schlesinger, S.; Aleksandrova, K.; Abar, L.; Vieria, A. R.; Vingeliene, S.; Polemiti, E.; Stevens, C. A. T.; Greenwood, D. C.; Chan, D. S. M.; Aune, D.; et al.Adult Weight Gain and Colorectal Adenomas—a Systematic Review and Meta-Analysis. Ann. Oncol. 2017, 28 (6), 1217–1229. https://doi.org/10.1093/annonc/mdx080.
(2) Vieira, A. R.; Abar, L.; Chan, D. S. M.; Vingeliene, S.; Polemiti, E.; Stevens, C.; Greenwood, D.; Norat, T.Foods and Beverages and Colorectal Cancer Risk: A Systematic Review and Meta-Analysis of Cohort Studies, an Update of the Evidence of the WCRF-AICR Continuous Update Project. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 2017, 28 (8), 1788–1802. https://doi.org/10.1093/annonc/mdx171. (3) Perera, P. S.; Thompson, R. L.; Wiseman, M. J.Recent Evidence for Colorectal Cancer Prevention Through Healthy Food, Nutrition, and Physical Activity: Implications for Recommendations. Curr. Nutr. Rep. 2012, 1 (1), 44–54. https://doi.org/10.1007/s13668-011-0006-7. (4) Comparing more and less developed countries | World Cancer Research Fund https://www.wcrf.org/dietandcancer/cancer-trends/comparing-more-and-less-developed-countries (accessed May 31, 2019). (5) Lin, Y.-P.Pharmacotherapy of Colorectal Cancer. J. TAIWAN Pharm. 2014, 30 (3), 86–91. (6) Chen, H.-Y.Pharmacotherapy of Colon Cancer in Each Stage. J. TAIWAN Pharm. 2015, 31 (4), 68–73. (7) Paraskar, A.; Soni, S.; Roy, B.; Papa, A.-L.; Sengupta, S.Rationally Designed Oxaliplatin-Nanoparticle for Enhanced Antitumor Efficacy. Nanotechnology 2012, 23 (7), 075103. https://doi.org/10.1088/0957-4484/23/7/075103. (8) Cabral, H.; Nishiyama, N.; Okazaki, S.; Koyama, H.; Kataoka, K.Preparation and Biological Properties of Dichloro(1,2-Diaminocyclohexane)Platinum(II) (DACHPt)-Loaded Polymeric Micelles. J. Control. Release 2005, 101 (1–3), 223–232. https://doi.org/10.1016/j.jconrel.2004.08.022. (9) Alcindor, T.; Beauger, N.Oxaliplatin: A Review in the Era of Molecularly Targeted Therapy. Current Oncology. 2011, pp 18–25. (10) Schellingerhout, D.; Leroux, L. G.; Hobbs, B. P.; Bredow, S.Impairment of Retrograde Neuronal Transport in Oxaliplatin-Induced Neuropathy Demonstrated by Molecular Imaging. PLoS One 2012, 7 (9), e45776. https://doi.org/10.1371/journal.pone.0045776. (11) Argyriou, A. a; Polychronopoulos, P.; Iconomou, G.; Chroni, E.; Kalofonos, H. P.A Review on Oxaliplatin-Induced Peripheral Nerve Damage. Cancer Treat. Rev. 2008, 34 (4), 368–377. https://doi.org/10.1016/j.ctrv.2008.01.003. (12) Alejandro, L. M.; Behrendt, C. E.; Chen, K.; Openshaw, H.; Shibata, S.Predicting Acute and Persistent Neuropathy Associated With Oxaliplatin. Am. J. Clin. Oncol. 2012, 00 (00), 1–7. https://doi.org/10.1097/COC.0b013e318246b50d. (13) Weickhardt, A.; Wells, K.; Messersmith, W.Oxaliplatin-Induced Neuropathy in Colorectal Cancer. J. Oncol. 2011, 2011, 201593. https://doi.org/10.1155/2011/201593. (14) Takimoto, C. H.; Arbuck, S. G.Topoisomerase I Targeting Agents: The Camptothecins. Cancer Chemother. Biother. Princ. Pract. 3rd ed. Philadelphia Lippincott Williams Wilkins 2001, 579–646. (15) Furin, A.; Guiotto, A.; Baccichetti, F.; Pasut, G.; Deuschel, C.; Bertani, R.; Veronese, F. M.Synthesis, Characterization and Preliminary Cytotoxicity Assays of Poly(Ethylene Glycol)-Malonato-Pt-DACH Conjugates. Eur. J. Med. Chem. 2003, 38 (7–8), 739–749. https://doi.org/10.1016/S0223-5234(03)00114-4. (16) Lagarce, F.; Cruaud, O.; Deuschel, C.; Bayssas, M.; Griffon-Etienne, G.; Benoit, J. P.Oxaliplatin Loaded PLAGA Microspheres:: Design of Specific Release Profiles. Int. J. Pharm. 2002, 242 (1–2), 243–246. https://doi.org/10.1016/S0378-5173(02)00166-7. (17) Han, I.; Kim, O. J.; Lee, G. Y.; Sung, Y. K.; Song, R.; Sohn, Y. S.Enhanced Antitumor Activity [Correction for Activitiy] of Trans(+/-)-1,2-Diaminocyclo- Hexaneglutamatoplatinum(II) Formulated with Stealth Liposome. Bioorg. Med. Chem. 2003, 11 (24), 5443–5447. https://doi.org/10.1016/J.BMC.2003.09.023. (18) Pal, A.; Khan, S.; Wang, Y. F.; Kamath, N.; Sarkar, A. K.; Ahmad, A.; Sheikh, S.; Ali, S.; Carbonaro, D.; Zhang, A.; et al.Preclinical Safety, Pharmacokinetics and Antitumor Efficacy Profile of Liposome-Entrapped SN-38 Formulation. Anticancer Res. 2005, 25 (1 A), 331–341. (19) Cabral, H.; Nishiyama, N.; Kataoka, K.Optimization of (1,2-Diamino-Cyclohexane)Platinum(II)-Loaded Polymeric Micelles Directed to Improved Tumor Targeting and Enhanced Antitumor Activity. J. Control. Release 2007, 121 (3), 146–155. https://doi.org/10.1016/j.jconrel.2007.05.024. (20) Uchino, H.; Matsumura, Y.; Negishi, T.; Koizumi, F.; Hayashi, T.; Honda, T.; Nishiyama, N.; Kataoka, K.; Naito, S.; Kakizoe, T.Cisplatin-Incorporating Polymeric Micelles (NC-6004) Can Reduce Nephrotoxicity and Neurotoxicity of Cisplatin in Rats. Br. J. Cancer 2005, 93 (6), 678–687. https://doi.org/10.1038/sj.bjc.6602772. (21) Miura, Y.; Takenaka, T.; Toh, K.; Wu, S.; Nishihara, H.; Kano, M. R.; Ino, Y.; Nomoto, T.; Matsumoto, Y.; Koyama, H.; et al.Cyclic RGD-Linked Polymeric Micelles for Targeted Delivery of Platinum Anticancer Drugs to Glioblastoma through the Blood–Brain Tumor Barrier. ACS Nano 2013, 7 (10), 8583–8592. https://doi.org/10.1021/nn402662d. (22) Matsumura, Y.Preclinical and Clinical Studies of NK012, an SN-38-Incorporating Polymeric Micelles, Which Is Designed Based on EPR Effect. Adv. Drug Deliv. Rev. 2011, 63 (3), 184–192. https://doi.org/10.1016/j.addr.2010.05.008. (23) Brown, S. D.; Nativo, P.; Smith, J.-A.; Stirling, D.; Edwards, P. R.; Venugopal, B.; Flint, D. J.; Plumb, J. A.; Graham, D.; Wheate, N. J.Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin. J. Am. Chem. Soc. 2010, 132 (13), 4678–4684. https://doi.org/10.1021/ja908117a. (24) Ghosh, P.; Han, G.; De, M.; Kim, C. K.; Rotello, V. M.Gold Nanoparticles in Delivery Applications. Adv. Drug Deliv. Rev. 2008, 60 (11), 1307–1315. https://doi.org/10.1016/j.addr.2008.03.016. (25) Jain, P. K.; Lee, K. S.; El-Sayed, I. H.; El-Sayed, M. A.Calculated Absorption and Scattering Properties of Gold Nanoparticles of Different Size, Shape, and Composition: Applications in Biological Imaging and Biomedicine. J. Phys. Chem. B 2006, 110 (14), 7238–7248. https://doi.org/10.1021/jp057170o. (26) Huang, X.; El-Sayed, I. H.; El-Sayed, M. A.Applications of Gold Nanorods for Cancer Imaging and Photothermal Therapy. Methods Mol. Biol. 2010, 624, 343–357. https://doi.org/10.1007/978-1-60761-609-2_23. (27) Huang, X.; Jain, P. K.; El-Sayed, I. H.; El-Sayed, M. A.Plasmonic Photothermal Therapy (PPTT) Using Gold Nanoparticles. Lasers Med. Sci. 2008, 23 (3), 217–228. https://doi.org/10.1007/s10103-007-0470-x. (28) Huang, X.; El-Sayed, I. H.; Qian, W.; El-Sayed, M. A.Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods. J. Am. Chem. Soc. 2006, 128 (6), 2115–2120. (29) Bardhan, R.; Lal, S.; Joshi, A.; Halas, N. J.Theranostic Nanoshells: From Probe Design to Imaging and Treatment of Cancer. Acc. Chem. Res. 2011, 44 (10), 936–946. https://doi.org/10.1021/ar200023x. (30) Ke, H.; Yue, X.; Wang, J.; Xing, S.; Zhang, Q.; Dai, Z.; Tian, J.; Wang, S.; Jin, Y.Gold Nanoshelled Liquid Perfluorocarbon Nanocapsules for Combined Dual Modal Ultrasound/CT Imaging and Photothermal Therapy of Cancer. Small 2014, 10 (6), 1220–1227. https://doi.org/10.1002/smll.201302252. (31) Topete, A.; Alatorre-Meda, M.; Iglesias, P.; Villar-Alvarez, E. M.; Barbosa, S.; Costoya, J. A.; Taboada, P.; Mosquera, V.Fluorescent Drug-Loaded, Polymeric-Based, Branched Gold Nanoshells for Localized Multimodal Therapy and Imaging of Tumoral Cells. ACS Nano 2014, 8 (3), 2725–2738. https://doi.org/10.1021/nn406425h. (32) Hirsch, L. R.; Stafford, R. J.; Bankson, J. A.; Sershen, S. R.; Rivera, B.; Price, R. E.; Hazle, J. D.; Halas, N. J.; West, J. L.Nanoshell-Mediated near-Infrared Thermal Therapy of Tumors under Magnetic Resonance Guidance. Proc. Natl. Acad. Sci. U. S. A. 2003, 100 (23), 13549–13554. https://doi.org/10.1073/pnas.2232479100. (33) Wu, C.; Yu, C.; Chu, M.A Gold Nanoshell with a Silica Inner Shell Synthesized Using Liposome Templates for Doxorubicin Loading and Near-Infrared Photothermal Therapy. Int. J. Nanomedicine 2011, 6, 807–813. https://doi.org/10.2147/IJN.S16701. (34) Liu, H.; Chen, D.; Tang, F.; Du, G.; Li, L.; Meng, X.; Liang, W.; Zhang, Y.; Teng, X.; Li, Y.Photothermal Therapy of Lewis Lung Carcinoma in Mice Using Gold Nanoshells on Carboxylated Polystyrene Spheres. Nanotechnology 2008, 19 (45), 455101. https://doi.org/10.1088/0957-4484/19/45/455101. (35) Park, H.; Yang, J.; Lee, J.; Haam, S.; Choi, I. I.-H.; Yoo, K. K.-H.Multifunctional Nanoparticles for Combined Doxorubicin and Photothermal Treatments. ACS Nano 2009, 3 (10), 2919–2926. https://doi.org/10.1021/nn900215k. (36) Lee, S.-Y.; Yang, C.-Y.; Peng, C.-L.; Wei, M.-F.; Chen, K.-C.; Yao, C.-J.; Shieh, M.-J.A Theranostic Micelleplex Co-Delivering SN-38 and VEGF SiRNA for Colorectal Cancer Therapy. Biomaterials 2016, 86, 92–105. https://doi.org/10.1016/j.biomaterials.2016.01.068. (37) Chen, C. L.; Kuo, L. R.; Chang, C. L.; Hwu, Y. K.; Huang, C. K.; Lee, S. Y.; Chen, K.; Lin, S. J.; Huang, J. D.; Chen, Y. Y.In Situ Real-Time Investigation of Cancer Cell Photothermolysis Mediated by Excited Gold Nanorod Surface Plasmons. Biomaterials 2010, 31 (14), 4104–4112. https://doi.org/10.1016/j.biomaterials.2010.01.140. (38) Lee, S. Y.; Peng, C. L.; Shieh, M. J.Combined Chemo-Photothermotherapy Using Gold Nanoshells on Drug-Loaded Micellar Templates for Colorectal Cancer Treatment. Part. Part. Syst. Charact. 2018, 35 (12), 1800334. https://doi.org/10.1002/ppsc.201800334. (39) Amatya, S.; Park, E. J.; Park, J. H.; Kim, J. S.; Seol, E.; Lee, H.; Choi, H.; Shin, Y. H.; Na, D. H.Drug Release Testing Methods of Polymeric Particulate Drug Formulations. Journal of Pharmaceutical Investigation. 2013. https://doi.org/10.1007/s40005-013-0072-5. (40) Hirsch, L. R.; Gobin, A. M.; Lowery, A. R.; Tam, F.; Drezek, R. A.; Halas, N. J.; West, J. L.Metal Nanoshells. Ann. Biomed. Eng. 2006, 34 (1), 15–22. https://doi.org/10.1007/s10439-005-9001-8. (41) Panchapakesan, B.; Book-Newell, B.; Sethu, P.; Rao, M.; Irudayaraj, J.Gold Nanoprobes for Theranostics. Nanomedicine (Lond). 2011, 6 (10), 1787–1811. https://doi.org/10.2217/nnm.11.155. (42) Peng, C.-L.; Tsai, H.-M.; Yang, S.-J.; Luo, T.-Y.; Lin, C.-F.; Lin, W.-J.; Shieh, M.-J.Development of Thermosensitive Poly(n-Isopropylacrylamide-Co-((2-Dimethylamino) Ethyl Methacrylate))-Based Nanoparticles for Controlled Drug Release. Nanotechnology 2011, 22 (26), 265608. https://doi.org/10.1088/0957-4484/22/26/265608. (43) Tsai, M.-H.; Peng, C.-L.; Yao, C.-J.; Shieh, M.-J.Enhanced Efficacy of Chemotherapeutic Drugs against Colorectal Cancer Using Ligand-Decorated Self-Breakable Agents. RSC Adv. 2015, 5 (112), 92361–92370. https://doi.org/10.1039/C5RA16175D. (44) Ning, S. T.; Lee, S. Y.; Wei, M. F.; Peng, C. L.; Lin, S. Y. F.; Tsai, M. H.; Lee, P. C.; Shih, Y. H.; Lin, C. Y.; Luo, T. Y.; et al.Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles. ACS Appl. Mater. Interfaces 2016, 8 (28), 17793–17804. https://doi.org/10.1021/acsami.6b04403. (45) Tsai, M. H.; Peng, C. L.; Yang, S. J.; Shieh, M. J.Photothermal, Targeting, Theranostic Near-Infrared Nanoagent with SN38 against Colorectal Cancer for Chemothermal Therapy. Mol. Pharm. 2017, 14 (8), 2766–2780. https://doi.org/10.1021/acs.molpharmaceut.7b00315. (46) Kidani, Y.; Inagaki, K.; Iigo, M.; Hoshi, A.; Kuretani, K.Antitumor Activity of 1,2-Diaminocyclohexaneplatinum Complexes against Sarcoma-180 Ascites Form. J. Med. Chem. 2002, 21 (12), 1315–1318. https://doi.org/10.1021/jm00210a029. (47) Crespo, M.Cyclometallated Platinum(IV) Compounds as Promising Antitumour Agents. J. Organomet. Chem. 2019, 879, 15–26. https://doi.org/10.1016/j.jorganchem.2018.10.008. (48) Bogojeski, J.; Volbeda, J.; Freytag, M.; Tamm, M.; Bugarčić, Ž. D.Palladium(II) Complexes with Highly Basic Imidazolin-2-Imines and Their Reactivity toward Small Bio-Molecules. Dalt. Trans. 2015, 44 (39), 17346–17359. https://doi.org/10.1039/C5DT02307F. (49) Kah, J. C. Y.; Grabinski, C.; Untener, E.; Garrett, C.; Chen, J.; Zhu, D.; Hussain, S. M.; Hamad-Schifferli, K.Protein Coronas on Gold Nanorods Passivated with Amphiphilic Ligands Affect Cytotoxicity and Cellular Response to Penicillin/Streptomycin. ACS Nano 2014, 8 (5), 4608–4620. https://doi.org/10.1021/nn5002886. (50) Kah, J. C. Y.; Chen, J.; Zubieta, A.; Hamad-Schifferli, K.Exploiting the Protein Corona around Gold Nanorods for Loading and Triggered Release. ACS Nano 2012, 6 (8), 6730–6740. https://doi.org/10.1021/nn301389c. (51) Dominguez-Medina, S.; Blankenburg, J.; Olson, J.; Landes, C. F.; Link, S.Adsorption of a Protein Monolayer via Hydrophobic Interactions Prevents Nanoparticle Aggregation under Harsh Environmental Conditions. ACS Sustain. Chem. Eng. 2013. https://doi.org/10.1021/sc400042h. (52) Weisz, O. A.Acidification and Protein Traffic. Int. Rev. Cytol. 2003. https://doi.org/10.1016/S0074-7696(03)01005-2. (53) Casey, J. R.; Grinstein, S.; Orlowski, J.Sensors and Regulators of Intracellular PH. Nature Reviews Molecular Cell Biology. 2010. https://doi.org/10.1038/nrm2820. (54) Hu, Y. B.; Dammer, E. B.; Ren, R. J.; Wang, G.The Endosomal-Lysosomal System: From Acidification and Cargo Sorting to Neurodegeneration. Translational Neurodegeneration. 2015. https://doi.org/10.1186/s40035-015-0041-1. (55) Agarwal, S.; Zhang, Y.; Maji, S.; Greiner, A.PDMAEMA Based Gene Delivery Materials. Materials Today. 2012. https://doi.org/10.1016/S1369-7021(12)70165-7. (56) Kou, L.; Sun, J.; Zhai, Y.; He, Z.The Endocytosis and Intracellular Fate of Nanomedicines: Implication for Rational Design. Asian J. Pharm. Sci. 2013. (57) Beik, J.; Abed, Z.; Ghoreishi, F. S.; Hosseini-Nami, S.; Mehrzadi, S.; Shakeri-Zadeh, A.; Kamrava, S. K.Nanotechnology in Hyperthermia Cancer Therapy: From Fundamental Principles to Advanced Applications. Journal of Controlled Release. 2016. https://doi.org/10.1016/j.jconrel.2016.05.062. (58) Kumar, R.; Roy, I.; Ohulchanskky, T. Y.; Vathy, L. A.; Bergey, E. J.; Sajjad, M.; Prasad, P. N.In Vivo Biodistribution and Clearance Studies Using Multimodal Organically Modified Silica Nanoparticles. ACS Nano 2010, 4 (2), 699–708. https://doi.org/10.1021/nn901146y. (59) Nallapareddy, S.; Eckhardt, S. G.; Messersmith, W.Irinotecan versus Oxaliplatin for Adjuvant Colon Cancer Therapy: Why Do the Results Differ? Curr. Colorectal Cancer Rep. 2008, 4 (3), 167–172. https://doi.org/10.1007/s11888-008-0027-9. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/74835 | - |
dc.description.abstract | 金奈米顆粒因其優異的生物相容性和特殊的光學特性近年來逐漸被廣泛應用於生醫檢測、診斷及治療等相關研究。藉由表面電漿共振效應,金奈米顆粒能有效地將特定波長光源的電磁波能量轉換為熱能釋出,因而成為重要的癌症光熱治療媒介材料之一。
本研究利用高分子微胞合成金奈米複合殼球,探討以其作為藥物傳輸系統搭載臨床化療藥物的疏水性衍生物所形成的奈米藥物結合光熱治療所產生的癌症治療效果。利用甲基丙烯酸二甲氨乙酯及己內酯單體所合成的兩性高分子在水相中可自組裝形成可包載疏水性化療藥物的奈米微胞,且其表面帶正電、能吸引帶負電的氯酸金離子,加入還原劑反應後可於微胞表面還原生成微小金奈米顆粒晶種並形成包覆奈米微胞的金殼。此金-高分子複合奈米殼球結構能在近紅外光波段有良好的吸收、具有極佳的生物相容性及光熱轉換能力,並且可有效攜載疏水的化療藥物衍生物如喜樹鹼的代謝產物SN-38與鉑類藥物Oxaliplatin的活性代謝成分DACHPt。殼球結構的金殼層可延緩藥物釋放,吸收近紅外光後產生的局部高溫能使載體結構變得不穩定進而釋放搭載的藥物,達到局部控制釋放的效果。藉由加強滲透度與留滯(enhanced permeability and retention)效應,本研究所製備的金奈米複合殼球能提升腫瘤區域的有效藥物濃度,促進化療治療效果。我們也在細胞及動物實驗中驗證,相較於化療或光熱治療等單一療法,利用此金奈米複合殼球同時進行化療合併光熱治療能顯著增強癌細胞毒殺及腫瘤抑制之效果。此外我們也嘗試利用自組裝之小動物內視鏡系統建立原處位直腸癌模式小鼠,以期未來能與光纖雷射併用、利用該原處位小鼠模式,進一步驗證此金奈米複合殼球載體應用於癌症光熱治療合併化療之潛力。 | zh_TW |
dc.description.abstract | Combination therapy is a novel strategy to improve the therapeutic outcome of conventional cancer treatment. In the present study, the poly[2-(N,N-dimethylamino)ethyl methacrylate]–poly(ε-caprolactone) (PDMA–PCL) micellar template-based gold nanoshells (GNS) is established as a multifunctional nanocarrier for hydrophobic chemotherapeutic compounds: one is 7-ethyl-10-hydroxycamptothecin (SN-38), a highly hydrophobic metabolite derived from irinotecan, and the other is dichloro(1,2-diaminocyclo-hexane)platinum(II) (DACHPt), the active metabolite of oxaliplatin. The GNS not only function as a drug delivery platform but also provide a remarkable photothermal effect, resulting in synergistically combined chemo-photothermal therapy. With the positively charged outstretched hydrophilic PDMA segments, chloroauric anions are attracted to the PDMA-PCL micellar surface and reduced to gold atoms in situ, forming small seeds that nucleate the subsequent growth of gold nanoshells. The GNS possess a broad surface plasmon resonance peak in the near-infrared (NIR) region and excellent photothermal conversion ability, thus, they can promote a temperature increase that is sufficient to ablate tumor cells under NIR laser irradiation. The local temperature increase also destabilizes the micellar and nanoshell structure, leading to a NIR-triggered release of the encapsulated drug. By exploiting the synergistic effects of combined chemo-photothermal therapy, the drug-loaded GNS exhibit significant tumor suppression compared to using single therapy such as chemotherapy or photothermal therapy alone, suggesting that this drug-loaded micellar GNS may be a potential candidate for future cancer therapy. In addition, we also set up a tailor-made small animal endoscopy system and successfully establish an orthotopic colorectal cancer mouse model, which can be involved as a powerful tool to evaluate the potency of the established nanomedicine in further preclinical studies. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T09:08:31Z (GMT). No. of bitstreams: 1 ntu-108-F01548008-1.pdf: 4132895 bytes, checksum: 4fc3f10bf58f06827b9fec44fb486983 (MD5) Previous issue date: 2019 | en |
dc.description.tableofcontents | 中文摘要 ------------------------------------------------------------------------- I
Abstract ------------------------------------------------------------------------- II Contents ------------------------------------------------------------------------ III List of Figures ------------------------------------------------------------------- IV List of Tables -------------------------------------------------------------------- VI Chapter 1. Introduction ----------------------------------------------------------- 1 Chapter 2. Materials and Methods ------------------------------------------------ 5 Chapter 3. Results and Discussions ---------------------------------------------- 19 3.1. Combined Chemo-Photothermal therapy Using Gold Nanoshells on SN-38-Loaded Micellar Templates for Colorectal Cancer Treatment ----------------- 19 3.2. DACHPt-Loaded Gold Nanoshells for Chemo-Photothermal Therapy in Colorectal Cancer -------------------------------------------------------------- 25 3.3. Establishment of a Tailor-made Small Animal Endoscopy System and the Orthotopic Colorectal Cancer Mouse Model ----------------------------------- 32 Chapter 4. Conclusions ---------------------------------------------------------- 34 Reference ----------------------------------------------------------------------- 35 Figures and Tables --------------------------------------------------------------- 43 | |
dc.language.iso | en | |
dc.title | 金奈米複合殼球載體於癌症光熱治療合併化療之應用 | zh_TW |
dc.title | Application of Micelle-Based Gold Nanoshells in Combined Chemo-Photothermal Cancer Therapy | en |
dc.type | Thesis | |
dc.date.schoolyear | 108-1 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 陳洋元,陳三元,張富雄,楊台鴻,賴秉杉 | |
dc.subject.keyword | 金奈米殼球,奈米藥物,化療,藥物傳輸,光熱治療,癌症治療,內視鏡, | zh_TW |
dc.subject.keyword | gold nanoshells,nanomedicine,chemotherapy,drug delivery,photothermal therapy,cancer therapy,endoscope, | en |
dc.relation.page | 65 | |
dc.identifier.doi | 10.6342/NTU201904267 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2019-11-07 | |
dc.contributor.author-college | 工學院 | zh_TW |
dc.contributor.author-dept | 醫學工程學研究所 | zh_TW |
顯示於系所單位: | 醫學工程學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-108-1.pdf 目前未授權公開取用 | 4.04 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。